ERBB2 and breast cancer: Breast cancer is a heterogeneous disease classified into four clinical subtypes based on the expression of hormone receptors (HR), including oestrogen and progesterone receptors (ER/PR) and human epidermal growth factor receptor 2 (HER2)1.